These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3056999)

  • 21. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations.
    Tamblyn RM; McLeod PJ; Abrahamowicz M; Laprise R
    CMAJ; 1996 Apr; 154(8):1177-84. PubMed ID: 8612253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacists' and general practitioners' views on parallel import of drugs].
    Gundersen R; Torgauten O; Olsen H
    Tidsskr Nor Laegeforen; 1999 Apr; 119(11):1586-8. PubMed ID: 10385799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dispensing practices for psychotropic medications amongst pharmacists in Karachi, Pakistan.
    Hasan S; Shad MU
    Heliyon; 2022 Nov; 8(11):e11298. PubMed ID: 36345515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience of the British health care system reform after the 1989 White Book and its possible application for the rational use of pharmaceuticals in Spain].
    Alfonso Galán MT
    Rev Sanid Hig Publica (Madr); 1994; 68(3):355-9. PubMed ID: 7716425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What drives inappropriate antibiotic dispensing? A mixed-methods study of pharmacy employee perspectives in Haryana, India.
    Barker AK; Brown K; Ahsan M; Sengupta S; Safdar N
    BMJ Open; 2017 Mar; 7(3):e013190. PubMed ID: 28255093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Legal implications of preparing and dispensing drugs under conditions not in a product's official labeling.
    Mandl FL; Greenberg RB
    Am J Hosp Pharm; 1976 Aug; 33(8):814-6. PubMed ID: 949065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some implications of legalized substitution of prescribed pharmaceuticals.
    PARKER JM
    Can Med Assoc J; 1962 Dec; 87(25):1318-21. PubMed ID: 13941488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dispensing doctors and prescribing pharmacists: a South African perspective.
    Gilbert L
    Soc Sci Med; 1998 Jan; 46(1):83-95. PubMed ID: 9464671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk evaluation and mitigation strategies: impact on patients, health care providers, and health systems.
    Shane R
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S6-S12. PubMed ID: 19966079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internet availability of prescription pharmaceuticals to the public.
    Bloom BS; Iannacone RC
    Ann Intern Med; 1999 Dec; 131(11):830-3. PubMed ID: 10610627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacy dispensing of electronically discontinued medications.
    Allen AS; Sequist TD
    Ann Intern Med; 2012 Nov; 157(10):700-5. PubMed ID: 23165661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of competition on prescription-drug-product substitution.
    Kralewski JE; Pitt L; Dowd B
    N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of supplying situation in pharmacies: II. Availability of medicaments and health appliances from the viewpoint of the patient].
    Macesková B; Holubková V
    Ceska Slov Farm; 2007 Apr; 56(2):95-7. PubMed ID: 17619307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The "pharmaceutical chain", important asset of health safety in France. Synthesis of the session].
    Santini C
    Ann Pharm Fr; 2008; 66(5-6):e9-12. PubMed ID: 19061724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nine-year sustained cost-containment impact of swiss pilot physicians-pharmacists quality circles.
    Niquille A; Ruggli M; Buchmann M; Jordan D; Bugnon O
    Ann Pharmacother; 2010 Apr; 44(4):650-7. PubMed ID: 20215496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 39. Prescribing and dispensing for drug misusers in primary care: current practice in Scotland.
    Matheson C; Bond CM; Hickey F
    Fam Pract; 1999 Aug; 16(4):375-9. PubMed ID: 10493708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dangerous and Hypnotic Drug Act.
    WHELAN WM
    Calif Med; 1961 Jan; 94(1):12-6. PubMed ID: 13784776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.